Despite this difficult year, our 25th Annual Scientific Meeting, held on the 23-25 July 2021 in Singapore, was a great success. The Meeting was fully online, and the sessions were well attended with over 1770 participants from 42 countries and from a range of health disciplines. For those unable to attend, highlights from the Annual Meeting including the opening session Poised to Take Over the World of Heart Failure Management and the Henry N. Neufeld lecture Atrial Fibrillation – What Does the Future Hold? as well as other sessions can be accessed at www.iscpcardio.org/iscp-singapore/.
The 2022 Annual Scientific Meeting will be held in Bucharest, Romania as a combined physical and digital event. The scheduled date for the meeting is 27-29 October 2022.
Please forward any news or information on upcoming conferences or meetings that you would like included in the December 2021 Newsletter to me at firstname.lastname@example.org by 2 December 2021.
Editors: John McNeil & Lisa Demos
Message from our President
Dear Esteemed Colleagues,
The end of the year is approaching. I recollect on the months past and my mind rests on an eventful second half of the year, which included the Annual Scientific Meeting organized by the Singapore team, albeit virtually. This year, we saw over 1700 delegates attending, all made possible by the mode of virtual meetings.
I acknowledge the work of the ISCP faculty reflected in this edition of the newsletter – high-quality scientific content, both in expanded form as textbooks and in bite-sized clips, like the new CLAPs which have generated much attention. Newest up our sleeves is a bi-monthly webinar series, affectionately dubbed the “A to Z of CV Pharmacotherapy”. In this series, we seek to go back to basics with Pharmacotherapy – the treatment of a disease or disorder with medicine. The principles which are taught to us in school are skilfully combined with real-world questions posed by practitioners like you and me. It is all made applicable through case-based discussions, hand-chosen by the pharmacists who lead the discussions. This is the true epitome of interdisciplinary collaboration!
As the world commences its reset of its stance with COVID-19, here’s a reminder to everyone to mark the dates for the 2022 ISCP Annual Scientific Meeting which will be happening in Bucharest, Romania. It will be an exciting new year, where travelling for meetings and conferences can hopefully start again. Until we meet in person, take care, and stay safe and healthy.
26th Annual Scientific Meeting – Singapore 2021
Young Investigator Award:
Yuto Kawase, University of Shizuoka, Japan – Compound A, a Ginger Extract, Significantly Reduces Pressure Overload-induced Systolic Heart Failure in Mice.
Oral Presentation Award Winners:
Shu Nakao, Ritsumeikan University, Kyoto Medical Center, Japan – Beta-3 Adrenergic Receptors in the Sinoatrial Node for Heart Rate Regulation
Eliana Susilowati, Biomedical Department, Medical Faculty, Brawijaya University, Malang, Indonesia- Polysaccharide Peptide of Ganoderma lucidum Reduce Endothelial Injury in Stable Angina and High-Risk Patients Photographs and information
Prof Shinjo Sonoda, Faculty of Medicine, Saga University Medical Center, Japan- Clinical Efficacy of Intracoronary Papaverine After Nicorandil Administration for Safe and Optimal Fractional Flow Reserve Measurement
Highlights from the 2021 Annual Scientific Meeting are available on the ISCP website
The ISCP General Assembly Meeting was held virtually in 2021. At the meeting, the new Board, Directors and Governors positions were notified, and the Treasurer and Secretary presented their reports. The ISCP Board approved free membership with access to resources on the website. As a result of the membership drive at ISCP2021, 1192 new non-voting members were welcomed.
Board Positions for 2022: Thomas Kahan (Sweden)- ISCP President; Sang Hong Baek (Republic of Korea) – President Elect; Jack Tan (Singapore)- Past President; Georg Noll (Switzerland)- Treasurer. Pablo Avanzas (Spain) Secretary
New ISCP Directors: Mungunchimeg Dagva (Mongolia); Alan Fong (Malaysi), Margarita Vejar (Chile)
CLAP in 60s series: CLAP (CataLysing Real World Pharmacotherapy) are short succinct videos and include Is Age a Comorbidity which Compels Dose Adjustment with DOACs? and are on the ISCP website, YouTube, and Facebook. Email any feedback and suggestions to ISCPCLAP@gmail.com.
ISCP Endorsed Meetings: 16 meetings were endorsed including P2Y12 Receptor Inhibitors in Non-ST-Segment Elevation Acute Coronary Syndrome Patients; Advances in Imaging: Optimising MR and CT in Daily Practice; Novel Pharmacological Treatments for the Prevention of Cardiovascular Events; Annual Fall Meeting 2021, ISCP Korea Chapter (K-ISCP)
Crowdsourcing survey, publication, and online digital educational programme: Crowdsourcing Consensus on the Utilisation of Antiplatelet Therapy in NSTE-ACS. Results have been published in the International Journal of Cardiology.
VIPFARMA project, an ISCP initiative led by Ricardo Lopez Santi. A publication titled Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project has been published in European Cardiology Review.
Is Age a comorbidity which compels dose adjustment with DOACs? Watch this presentation by Koji Hasegawa Kyoto Medical Center, Marvin Sim, National Healthcare Group Pharmacy on Facebook
Expert reviews – 12 were published in 2020 and 2021. They include: Hypertension and Stroke: Update on Treatment– Wajngarten M, Sampaio Silva G; Testosterone and the Heart– Kirby MG, Hackett G, Ramachandran S; The Role Of Inflammation In Diabetes: Current Concepts And Future Perspectives– Tsalamandris S, Antonopoulos AS, Oikonomou E, et al.
Webinars added in 2021 include: Optimal Antiplatelet Therapy In NSTE-ACS: Results from A Novel Crowdsourcing Survey – Juan Carlos Kaski and Deepak Bhatt.
A-Z Cardiovascular Pharmacotherapy Webinar Series: this is a new activity and has included: All about Aspirin with John McNeil, Koji Hasegawa and Juan Carlos Kaski and moderated by Doreen Tan, Beta-blocker sotalol vs flecainide and propafenone Do’s and don’ts of taming the AF Rhythm– with George Dan, Takanori Ikeda and Grace Chang and Evolocumab (PCSK9i): A bride for the old faithful statin?– with speaker Heinz Drexel, Panel – Alberto J Lorenzatti and Krzysztof Filipiak, Moderators Franco Cheng and Doreen Tan.
News from World Heart Federation (WHF)
Clean Air, Smart Cities, Healthy Hearts: WHF released new Policy Brief on air pollution and cardiovascular disease.
Improving Cardiovascular Health through Digital Care: article co-authored by WHF President Prof Fausto Pinto, CEO Jean-Luc Eiselé as well as others published in The Lancet focuses on the need for greater equity in access to digital health tools and systems, particularly in the wake of the COVID-19 pandemic.
The new WHF Roadmap for Hypertension: builds on the previous 2015 edition and aims to support the diagnosis, prevention, treatment, and management of raised blood pressure.
World Heart Summit: Time to Act on Obesity: webinar 14 October-22 November 2021.
World Obesity Federation (WOF) and WHF obesity and CVD modules: 6-module learning path has been launched exploring the interrelationship between obesity and CVD. Available in English, Spanish, French and Portuguese.
COVID-19 Study: Early study results presented at the ESC Congress in August with final analysis expected at the AHA Scientific Sessions in November.
COVID-19 and CVD Resource Hub: for information and stories from frontline workers.
Digital Health and CVD: video with Dr Tedros’ message on World Heart Day.
COVID-19, Digital Health, and Tackling CVD: published in The Lancet
ISCP Book Series: Current Cardiovascular Therapy
The Current Cardiovascular Therapy Series provide both an in-depth view of the science and pharmacology behind these drugs and a practical guide to their usage. Each volume contains practical illustrations and is designed to improve understanding and practical usage of cardiovascular drugs in specific clinical areas.
The Springer series includes the following books available as e-books or in soft cover at a discounted rate for ISCP members: Antiarrhythmic Drugs; Antiplatelet and Anticoagulation Therapy; Pharmacological Treatment of Acute Coronary Syndromes; Atrial Fibrillation Therapy; Cardiac Drugs in Pregnancy; Pharmacotherapy in Aortic Disease; Pharmacologic Trends of Heart Failure; Pharmacological Treatment of Chronic Stable Angina Pectoris; ACEi and ARBS in Hypertension and Heart Failure; Treatment of Pulmonary Hypertension.
European Cardiology Review (ECR) – Official ISCP Journal
The European Cardiology Review (ECR) is a PubMed indexed, peer-reviewed journal comprising review articles, editorials and case reports. The journal is led by Editor-in-Chief Juan Carlos Kaski, along with Associate Editor Pablo Avanzas and is supported by an editorial board of world-renowned physicians.
The current volume (16) is available here with all articles free to view via the journal website. Recent additions include Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases.
If you are interested in becoming involved in the journal whether as an author, reviewer or board member please contact Ashlynne Merrifield, Managing Editor, email@example.com.
Upcoming Meetings, Courses and Workshops
17th Malaysian Cardiovascular Interventional Symposium
11-12 November 2021
Kuala Lumpur, Malaysia
ESC-Asia with APSC & AFC
2-4 November 2021
Russian National Congress of Cardiology 2021
21-23 October 2021
St Petersburg, Russia
Great Wall International Congress of Cardiology/AHS Congress
29-31 October 2021
Beijing and virtual
To unsubscribe to the Newsletters please notify: Begoña Lugg the ISCP Administration Officer at firstname.lastname@example.org